Accessibility Toolbar

Bascom Palmer Eye Institute

Byron L. Lam, M.D.

Bascom Palmer Eye Institute Initiates Pioneering Gene Therapy Targeting Choroideremia

November 17, 2015

A research team at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine has performed gene therapy on a 47-year-old man as part of a Phase 2 clinical trial to treat Choroideremia (CHM), a rare inherited cause of blindness. The Food and Drug Administration approved clinical trial will ultimately treat six patients with CHM to help determine the safety and efficacy of this novel treatment.

Read more about the pioneering gene therapy »

John Guy, M.D.

Scientists at Bascom Palmer Eye Institute Test New Gene Therapy for Vision Loss

October 13, 2015

Researchers at Bascom Palmer Eye Institute funded by the National Institutes of Health have developed a novel mouse model for the vision disorder Leber hereditary optic neuropathy (LHON), and found that they can use gene therapy to improve visual function in the mice. LHON is one of many diseases tied to gene mutations that damage the tiny energy factories that our cells, called mitochondria.

Read more on the gene therapy research »

Eduardo C. Alfonso, M.D.

Dr. Eduardo C. Alfonso Becomes President of Pan American Association of Ophthalmology

August 18, 2015

Eduardo C. Alfonso, M.D., Chairman of the Department of Ophthalmology and holder of the Kathleen and Stanley J. Glaser Chair in Ophthalmology, was recently installed as President of the Pan American Association of Ophthalmology (PAAO) at its 31st Congress in Bogotá, Colombia. The PAAO’s mission is to provide continuing education, prevent blindness, and promote scientific and cultural exchange among ophthalmologists.

Read more about Dr. Alfonso and the PAAO meeting »